Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1 -Negative Myeloproliferative Neoplasm.

Autor: Abbou, Norman^1,2 (AUTHOR), Piazzola, Pauline³ (AUTHOR), Gabert, Jean^1,2 (AUTHOR), Ernest, Vincent⁴ (AUTHOR), Arcani, Robin^2,5 (AUTHOR), Couderc, Anne-Laure⁶ (AUTHOR), Tichadou, Antoine³ (AUTHOR), Roche, Pauline³ (AUTHOR), Farnault, Laure³ (AUTHOR), Colle, Julien^2,3 (AUTHOR), Ouafik, L'houcine^7,8 (AUTHOR), Morange, Pierre^2,4 (AUTHOR), Costello, Régis^2,3,9 (AUTHOR), Venton, Geoffroy^2,3,9 (AUTHOR) geoffroy.venton@ap-hm.fr

Publikováno v: Cells (2073-4409). Jan2023, Vol. 12 Issue 1, p105. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characteristics of JAK2 unmutated erythrocytosis: Distinctive traits between polycythemia vera and non-polycythemia vera patients

Autor: Ernest, Vincent, Abbou, Norman, Tichadou, Antoine, Arcani, Robin, Venton, Geoffroy

Publikováno v: In European Journal of Internal Medicine January 2023 107:113-115

Additional file 1: of Description of 22 new alpha-1 antitrypsin genetic variants

Autor: CÊline Renoux, Marie-FrançOise Odou, Tosato, Guillaume, Teoli, Jordan, Abbou, Norman, Lombard, Christine, Zerimech, Farid, Porchet, Nicole, Cellier, Colette Chapuis, Balduyck, Malika, Joly, Philippe

Figure S1. A1AT phenotypes: (A) Coomassie blue stained polyacrylamide gel (B) agarose gel followed by immunofixation. 1:M1; 2:M2S; 3:M1M4; 4,5,6: M2P; 7:M2SRoubaix; 8: IM; 9:M2SRoubaix; 10,11:M1Z; 12:M1; 13:M2S; 14:M1S. The SRoubaix variant has clear

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc64bf29e364040c4bcae71123bdba83